Bowhead Specialty Holdings Inc. (NYSE:BOW) Receives $33.50 Consensus PT from Brokerages

Shares of Bowhead Specialty Holdings Inc. (NYSE:BOWGet Free Report) have been given a consensus recommendation of “Hold” by the nine ratings firms that are presently covering the firm, Marketbeat reports. Seven analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $33.00.

Several equities analysts have recently weighed in on BOW shares. Citizens Jmp dropped their price objective on shares of Bowhead Specialty from $38.00 to $35.00 and set a “market outperform” rating on the stock in a report on Monday, April 13th. JPMorgan Chase & Co. raised their target price on Bowhead Specialty from $30.00 to $33.00 and gave the company a “neutral” rating in a research note on Monday, July 20th. UBS Group set a $28.00 target price on Bowhead Specialty in a research report on Thursday, May 21st. Weiss Ratings raised Bowhead Specialty from a “hold (c-)” rating to a “hold (c)” rating in a research note on Tuesday, June 23rd. Finally, Piper Sandler downgraded Bowhead Specialty from an “overweight” rating to a “hold” rating and set a $34.00 price target on the stock. in a research note on Monday, August 3rd.

View Our Latest Stock Analysis on Bowhead Specialty

Bowhead Specialty Stock Performance

NYSE:BOW opened at $33.46 on Tuesday. The company has a quick ratio of 0.49, a current ratio of 0.49 and a debt-to-equity ratio of 0.31. Bowhead Specialty has a twelve month low of $21.21 and a twelve month high of $35.07. The company has a fifty day moving average of $29.78 and a 200-day moving average of $26.46. The firm has a market capitalization of $1.10 billion, a P/E ratio of 18.09, a P/E/G ratio of 1.01 and a beta of -0.11.

Bowhead Specialty (NYSE:BOWGet Free Report) last issued its earnings results on Monday, August 3rd. The company reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.47 by $0.01. The business had revenue of $163.86 million for the quarter, compared to analyst estimates of $278.69 million. Bowhead Specialty had a net margin of 10.11% and a return on equity of 14.05%. As a group, sell-side analysts anticipate that Bowhead Specialty will post 1.97 EPS for the current year.

Hedge Funds Weigh In On Bowhead Specialty

A number of institutional investors have recently modified their holdings of the company. Langdon Equity Partners acquired a new stake in Bowhead Specialty in the 4th quarter valued at $28,000. Versant Capital Management Inc raised its holdings in Bowhead Specialty by 262.6% during the second quarter. Versant Capital Management Inc now owns 1,037 shares of the company’s stock worth $31,000 after buying an additional 751 shares during the last quarter. Raymond James Financial Inc. acquired a new position in Bowhead Specialty during the second quarter worth $52,000. CWM LLC lifted its stake in shares of Bowhead Specialty by 257.7% in the fourth quarter. CWM LLC now owns 1,481 shares of the company’s stock valued at $42,000 after buying an additional 1,067 shares in the last quarter. Finally, Parallel Advisors LLC lifted its stake in shares of Bowhead Specialty by 181.4% in the first quarter. Parallel Advisors LLC now owns 1,652 shares of the company’s stock valued at $37,000 after buying an additional 1,065 shares in the last quarter.

About Bowhead Specialty

(Get Free Report)

Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.

Further Reading

Analyst Recommendations for Bowhead Specialty (NYSE:BOW)

Receive News & Ratings for Bowhead Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bowhead Specialty and related companies with MarketBeat.com's FREE daily email newsletter.